Bryson Katona
Penn Medicine Lynch Syndrome Program Director · University of Pennsylvania Health System
Credentials: · · · · · · · ·
History
PresentPenn Medicine Lynch Syndrome · University of Pennsylvania Health System
- Present
King Center for Lynch Syndrome at Penn Medicine's Abramson Cancer Center · University of Pennsylvania Health System
- 1998–2002
- 1999–2002
Research
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
Nature · 2015 · 399 citations
β-Hydroxybutyrate suppresses colorectal cancer
Nature · 2022 · 267 citations
The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival
Journal of Clinical Oncology · 2022 · 208 citations
19 papers
17 papers
17 papers
15 papers
14 papers
13 papers
12 papers
11 papers
Grants
- 2022–2024
Defining the Phenotype and Cancer Penetrance of CTNNA1 Loss-of-Function Germline Variants
National Cancer Institute · R21
Contact PI · $416.9K · University of Pennsylvania
- 2019–2021
Menin Regulates Colonic Epithelial Cell Growth Through LXR Repression
National Institute of Diabetes and Digestive and Kidney Diseases · R03
Contact PI · $242.9K · University of Pennsylvania
- 2015–2020
Menin/MLL Promotes Cell Survival in the Setting of EGFR Inhibition
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $818.6K · University of Pennsylvania
Clinical trials
- 2024–2027
Principal investigator · Enrolling by invitation
Abramson Cancer Center at Penn Medicine
- 2022–2027
Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention
Principal investigator · Active not recruiting
Abramson Cancer Center at Penn Medicine
- 2021–2028
CTNNA1 Familial Expansion Study
Principal investigator · Recruiting
Abramson Cancer Center at Penn Medicine
- 2014–2019
Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
Principal investigator · Completed
University of Pennsylvania
Honors
CGAF